Tilmicosin is a macrolide antibiotic. It is used in veterinary anesthetic for the analysis of bovine respiratory ache and enzootic pneumonia acquired by Mannheimia (Pasteurella) haemolytica in sheep.
Tilmicosin is a broad-spectrum semi-synthetic antibacterial macrolide antibacterial actinic from tylosin. It has an antibacterial spectrum that is predominantly able adjoin Mycoplasma, Pasteurella and Haemophilus spp. and assorted Gram-positive bacilli such as Staphylococcus spp. It is believed to affect bacterial protein synthesis.
Cross-resistance amid tilmicosin and added macrolide antibiotics has been observed. Following subcutaneous injection, tilmicosin is excreted mainly via the acerbity into the faeces, with a baby admeasurement getting excreted via the urine.